External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Navin Fluorine International / Equity Bottom-Up

<ul><li>We are revising our estimates downward due to a slower-than-expected recovery in the Specialty Chemicals and Ref Gas verticals.</li><li>Additionally, we are adjusting our outlook for project stabilization and optimal capacity utilization in the HFO segment, considering the potential delay in capacity increase for HFO 2.0</li><li>We roll forward our estimates to 27x FY26E, valuing the stock at TP of Rs 3,080/share, which implies a downside of 9% from the CMP.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

We are revising our estimates downward due to a slower-than-expected recovery in the Specialty Chemicals and Ref Gas verticals.Additionally, we are adjusting our outlook for project stabilization and optimal capacity utilization in the HFO segment, considering the potential delay in capacity increase for HFO 2.0We roll forward our estimates to 27x FY26E, valuing the stock at TP of Rs 3,080/share, which implies a downside of 9% from the CMP.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Navin Fluorine International Ltd - Near-Term Business Woes & CEO Search Continues